New Treatment for the Cognitive and Emotional Deficits Linked with Paclitaxel-Induced Peripheral Neuropathy in Mice.
Ignacio Martínez-Martel, Xue Bai, Gerard Batallé, Olga Pol · Antioxidants (Basel, Switzerland) · 2022
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In mice, the daily administration of HRW also progressively reduced the thermal allodynia induced by PTX injection ( p < 0.001; one-way ANOVA, against vehicle plus vehicle-treated animals; Figure 1 B,D), but five and three days of treatment with HRW, administered at 1T and 2T per day, were required for full inhibition. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in mice. The daily administration of HRW also progressively reduced the thermal allodynia induced by PTX injection ( p < 0.001; one-way ANOVA, against vehicle plus vehicle-treated animals; Figure 1 B,D), but five and three days of treatment with HRW, administered at 1T and 2T per day, were required for full inhibition.
What the Researchers Studied
The researchers studied mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 0.3 mM H₂ (≈0.605 mg/L); reported treatment duration: 3 days. The daily administration of HRW also progressively reduced the thermal allodynia induced by PTX injection ( p < 0.001; one-way ANOVA, against vehicle plus vehicle-treated animals; Figure 1 B,D), but five and three days of treatment with HRW, administered at 1T and 2T per day, were required for full inhibition. The authors concluded that in summary, this research demonstrates that the repetitive administration of HRW inhibited allodynia, memory deficits, and anxious-depressive-like behaviors provoked by PTX. In this study, using male mice injected with paclitaxel (PTX), the researchers examined the effects of systemic treatment with hydrogen-rich water (HRW) in: (i) the mechanical and thermal allodynia provoked by PTX and the pathways involved. (ii) the memory deficits, anxiety- and depressive-like behaviors associated with PTX-induced peripheral neuropathy (PIPN). (iii) the plasticity (p-extracellular signal-regulated protein kinase; p-ERK ½), nociceptive (p-protein kinase B, p-Akt), inflammatory (p-nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; p-IKBα), and oxidative (4-hydroxynonenal: 4-HNE) alterations provoked by PIPN in the prefrontal cortex (PFC).
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment. The hydrogen delivery method was hydrogen-rich water. The source-reported hydrogen concentration was 0.3 mM H₂ (≈0.605 mg/L). The reported treatment duration was 3 days.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.